About Us | Contact

Marlyn F Goldberg

NPI1629066519
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$75,388.72
from 12 payments in the last 6 years

Total Cash or Cash Equivalent

$74,977.80
from 5 payments in the last 6 years

Total In-kind Items & Services

$410.92
from 7 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
07/30/2021 General (Non-Research) In-kind items and services Food and Beverage $16.96 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812694909
07/28/2019 General (Non-Research) In-kind items and services Food and Beverage $79.76 Details
Payment from Bausch & Lomb, a division of Bausch Health US, LLC
Payment Record ID 684418487
07/28/2019 General (Non-Research) In-kind items and services Food and Beverage $13.11 Details
Payment from Bausch & Lomb, a division of Bausch Health US, LLC
Payment Record ID 684418485
07/31/2019 General (Non-Research) In-kind items and services Food and Beverage $115.25 Details
Payment from Regeneron Healthcare Solutions, Inc.
Payment Record ID 673385055
01/04/2018 General (Non-Research) Cash or cash equivalent Food and Beverage $14.39 Details
Payment from Alimera Sciences, Inc.
Payment Record ID 616876599
07/27/2018 General (Non-Research) In-kind items and services Food and Beverage $90.13 Details
Payment from Regeneron Healthcare Solutions, Inc.
Payment Record ID 570217929
12/13/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $8325.00 Details
Payment from Astellas Pharma Global Development
Payment Record ID 567655352
12/13/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $66600.00 Details
Payment from Astellas Pharma Global Development
Payment Record ID 567655347
12/19/2017 General (Non-Research) Cash or cash equivalent Food and Beverage $22.14 Details
Payment from Alimera Sciences, Inc.
Payment Record ID 511013211
12/15/2017 General (Non-Research) In-kind items and services Food and Beverage $74.27 Details
Payment from CooperVision Inc.
Payment Record ID 495384879
07/31/2017 General (Non-Research) In-kind items and services Food and Beverage $21.44 Details
Payment from Valeant Pharmaceuticals North America LLC
Payment Record ID 444343715
05/24/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $16.27 Details
Payment from Alimera Sciences, Inc.
Payment Record ID 419115667
;